Home

Evaxion A/S - American Depositary Share (EVAX)

6.2000
-0.4300 (-6.49%)
NASDAQ · Last Trade: Dec 10th, 10:27 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close6.630
Open6.630
Bid6.200
Ask6.270
Day's Range6.147 - 6.630
52 Week Range1.200 - 12.15
Volume28,843
Market Cap234.97M
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume109,354

Chart

About Evaxion A/S - American Depositary Share (EVAX)

Evaxion Biotech A/S is a biotechnology company that focuses on the development of innovative immunotherapies and personalized cancer treatments using its proprietary artificial intelligence platform. The company specializes in designing and developing therapeutic vaccines that harness the body's immune system to target and destroy cancer cells. By leveraging advanced machine learning algorithms, Evaxion aims to identify optimal vaccine candidates tailored to individual patients, with the goal of providing more effective and customized treatment options for various types of cancer and infectious diseases. Read More

News & Press Releases

12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · October 17, 2025
Top stock movements in today's session.chartmill.com
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · October 17, 2025
Which stocks are gapping on Friday?chartmill.com
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · October 17, 2025
Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happenedstocktwits.com
Via Stocktwits · September 25, 2025
Earnings Scheduled For August 14, 2025benzinga.com
Via Benzinga · August 14, 2025
Insights Ahead: Evaxion Biotech's Quarterly Earningsbenzinga.com
Via Benzinga · August 13, 2025
A Look at Evaxion Biotech's Upcoming Earnings Reportbenzinga.com
Via Benzinga · May 26, 2025
Earnings Scheduled For November 6, 2025benzinga.com
Via Benzinga · November 6, 2025
What's Next: Evaxion Biotech's Earnings Previewbenzinga.com
Via Benzinga · November 5, 2025
This Draganfly Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursdaybenzinga.com
Via Benzinga · October 30, 2025
Evaxion Appoints Helen Tayton-Martin As Chief Executivestocktwits.com
Via Stocktwits · October 27, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 17, 2025
Top movers in Friday's sessionchartmill.com
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · October 17, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · October 15, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 7, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
Via Benzinga · September 26, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025
COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.
By Evaxion · Via GlobeNewswire · August 11, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 14, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · June 25, 2025
Evaxion announces business update and first quarter 2025 financial results
COPENHAGEN, Denmark, May 27, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces first quarter 2025 financial results.
By Evaxion Biotech · Via GlobeNewswire · May 27, 2025
Earnings Scheduled For May 27, 2025benzinga.com
Via Benzinga · May 27, 2025
Sidoti Events, LLC's Virtual May Micro-Cap Conference
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Conference taking place Wednesday and Thursday, May 21-22, 2025. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Via ACCESS Newswire · May 20, 2025
Evaxion announces business update and full year 2024 financial results
By Evaxion Biotech · Via GlobeNewswire · April 1, 2025